Li, C., Tung, M., Tsai, C., Ju, T., & Tseng, T. (2025). Discovery and characterization of novel hematopoietic prostaglandin D synthase inhibitors from traditional Chinese medicine: The bioactive potential of dihydroberberine in treatments of Duchenne muscular dystrophy and inflammation-related diseases. Journal of Enzyme Inhibition & Medicinal Chemistry, 40(1), 1. https://doi.org/10.1080/14756366.2025.2555624
Chicago Style (17th ed.) CitationLi, Cheng-Han, Min-Che Tung, Cheng-Kuan Tsai, Tz-Chuen Ju, and Tien-Sheng Tseng. "Discovery and Characterization of Novel Hematopoietic Prostaglandin D Synthase Inhibitors from Traditional Chinese Medicine: The Bioactive Potential of Dihydroberberine in Treatments of Duchenne Muscular Dystrophy and Inflammation-related Diseases." Journal of Enzyme Inhibition & Medicinal Chemistry 40, no. 1 (2025): 1. https://doi.org/10.1080/14756366.2025.2555624.
MLA (9th ed.) CitationLi, Cheng-Han, et al. "Discovery and Characterization of Novel Hematopoietic Prostaglandin D Synthase Inhibitors from Traditional Chinese Medicine: The Bioactive Potential of Dihydroberberine in Treatments of Duchenne Muscular Dystrophy and Inflammation-related Diseases." Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 40, no. 1, 2025, p. 1, https://doi.org/10.1080/14756366.2025.2555624.
